The Mystery Of Rls And Wed: Unraveling The Meaning And Impact

Restless legs syndrome (RLS) is also known as Willis-Ekbom disease (WED). It is a chronic neurological disorder that causes an overwhelming urge to move one's legs, accompanied by an unpleasant feeling in the legs that is often described as aching, tingling, or crawling. The condition affects 5-15% of adults in industrialised countries and can be treated with medication and lifestyle changes, but there is currently no cure.

RLS/WED is a neurological disorder

Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a neurological disorder that causes unpleasant or uncomfortable sensations in the legs and an irresistible urge to move them. Symptoms typically occur in the late afternoon or evening and are most intense at night when the body is at rest. RLS can severely disrupt sleep, making it difficult to fall asleep or return to sleep after waking up. Moving the legs or walking typically relieves the discomfort, but the sensations often recur once the movement stops.

RLS is both a sleep disorder and a movement disorder. As a sleep disorder, the symptoms are triggered by resting and attempting to sleep. As a movement disorder, people with RLS are forced to move their legs to relieve the symptoms.

RLS is a chronic condition that can begin at any age and affects both males and females, although it is more common in females. Many individuals who are severely affected are middle-aged or older, and the symptoms typically become more frequent and last longer with age.

The exact cause of RLS is unknown, but it is often associated with specific medical conditions, certain medications, or genetic factors. It is believed to be related to dysfunction in the basal ganglia region of the brain, which controls movement using the brain chemical dopamine. Disruption of dopamine levels in the brain can result in involuntary movements.

RLS is a lifelong condition with no cure, but treatments are available to ease the symptoms, including medications and lifestyle changes such as regular exercise and improved sleep hygiene.

RLS/WED causes unpleasant sensations in the legs

Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a neurological disorder that causes unpleasant sensations in the legs. These sensations can be described as an irresistible urge to move the legs, which is often accompanied by uncomfortable feelings such as itching, prickling, pulling, crawling, or throbbing. The sensations typically occur when the individual is resting or inactive, and can make it difficult to fall asleep or return to sleep after waking up.

The unpleasant sensations associated with RLS can vary in nature and intensity. They are often felt in the calf but may occur anywhere from the thigh to the ankle, and can affect one or both legs. In some cases, individuals may also experience these sensations in their arms or other parts of the body. The need to move the affected limb provides temporary relief from the discomfort.

The specific cause of RLS is not fully understood, but it is believed to be related to the functioning of the basal ganglia, a part of the brain that regulates movement using the neurotransmitter dopamine. Disruptions in dopamine levels can lead to involuntary movements, and individuals with Parkinson's disease, a movement disorder, have an increased risk of developing RLS. Additionally, there may be a link between RLS and low levels of iron in the brain, even when blood tests show normal iron levels.

RLS can severely disrupt sleep, leading to daytime fatigue, sleepiness, and irritability. It is estimated that up to 10% of the US population may have RLS, with women being more likely to be affected than men. While there is no cure for RLS, treatments are available to manage symptoms, including lifestyle changes and medications.

RLS/WED can be treated with medication

Restless legs syndrome (RLS), or Willis-Ekbom disease (WED), is a neurologic disorder characterised by an uncomfortable urge to move the legs, accompanied by an uncomfortable tingling sensation. While RLS symptoms may never fully disappear, they can be significantly improved through a combination of lifestyle changes, vitamin and mineral supplements, medical devices, and medication.

Dopaminergic Drugs

Dopaminergic drugs are considered the first line of treatment for RLS/WED. Levodopa was the first drug used to treat RLS in 1982. While effective, it has augmentation as a side effect at all doses. Dopamine agonists such as pramipexole, ropinirole, and rotigotine are now used as the first-line treatment for RLS. However, augmentation still occurs to varying degrees with these drugs.

Α2δ Ligands

Α2δ ligands, including gabapentin enacarbil, gabapentin, and pregabalin, have been used to treat RLS since 2000. They are less frequently prescribed than dopaminergic drugs, but they do not cause augmentation. Pregabalin is a relatively new drug that has been the focus of just a few clinical studies since 2010.

Opioids

Opioids are approved as a second-line therapy to treat refractory RLS. They may be prescribed for people with severe RLS symptoms that do not respond to other treatments. However, opioids are highly addictive, and most people develop a tolerance over time.

Iron Supplements

Many cases of RLS are associated with iron deficiency, which can be treated with iron supplements. Doctors may prescribe iron supplements alone or in conjunction with other medications.

Anti-Seizure Drugs

Anti-seizure drugs are often used for people who experience pain alongside their other RLS symptoms. These drugs are gaining popularity as an RLS treatment because they seem to be as effective as dopaminergic agonists, but are less likely to cause augmentation of RLS symptoms. The FDA has approved gabapentin enacarbil for use in RLS, and pregabalin also shows promising results for RLS symptoms and sleep quality.

Benzodiazepines

Benzodiazepines do not have a direct effect on RLS symptoms, but they may help individuals with RLS sleep more soundly. They are usually only prescribed if other drugs don't work because of the potential for developing a tolerance.

Other Substances

A few substances, such as valerian and valproic acid, are sometimes used to treat RLS despite not being FDA-approved. However, due to the lack of research on their efficacy and side effects, the American Academy of Sleep Medicine recommends against using these for RLS.

RLS/WED is also known as Willis-Ekbom disease

Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a chronic neurological disorder that causes an overwhelming urge to move one's legs. The condition is characterised by uncomfortable sensations in the legs, which can be described as aching, throbbing, pulling, itching, crawling, or creeping. These sensations are usually most intense at night, when the individual is resting, and can severely disrupt sleep. RLS can also affect the arms, and occasionally the chest or head, but this is less common.

The sensations of RLS are often temporarily relieved by movement, such as walking or stretching. However, symptoms often return once movement stops. RLS can range in severity, with some people experiencing only minor annoyance, while others suffer major disruptions to their sleep and quality of life.

RLS is both a sleep disorder and a movement disorder. As a sleep disorder, the symptoms are triggered by resting and attempting to sleep. As a movement disorder, people with RLS are forced to move their legs to relieve their symptoms.

The condition is estimated to affect 5-15% of the adult population in industrialised countries, although there is some variation depending on geographical location. RLS occurs in both males and females, but females are more likely to be affected. The symptoms of RLS typically become more frequent and last longer with age, and the condition is generally lifelong with no cure. However, treatments are available to ease the symptoms.

RLS is idiopathic in most cases, but it often runs in families and specific gene variants have been associated with the condition. Low levels of iron in the brain, known as iron insufficiency, may also be responsible for RLS. Additionally, RLS may be related to dysfunction in the basal ganglia, a part of the brain that controls movement using the brain chemical dopamine. Disruption of dopamine levels in the brain can result in involuntary movements, and individuals with Parkinson's disease have an increased risk of developing RLS.

RLS/WED affects 5-15% of adults in industrialised countries

Restless legs syndrome (RLS), also known as Willis–Ekbom disease (WED), is a chronic neurological disorder that causes an overwhelming urge to move one's legs. It affects 2.5–15% of the American population, with females being more commonly affected than males. Globally, the prevalence of RLS/WED is estimated to be between 5% and 15%.

The urge to move the legs is often accompanied by unpleasant sensations, such as aching, tingling, or crawling, which can be temporarily relieved by moving the legs. These feelings typically occur during periods of rest, making it difficult to fall or stay asleep. As a result, people with RLS/WED may experience sleep disruption, leading to daytime sleepiness, low energy, irritability, or depression.

RLS/WED can affect people of all ages, but it is more common in older individuals. Pregnancy can also increase the risk of developing RLS/WED, with up to one-third of pregnant women experiencing the condition during their third trimester.

The exact cause of RLS/WED is unknown, but it is believed to be associated with changes in dopamine and iron levels in the brain. Risk factors include low iron levels, kidney failure, Parkinson's disease, diabetes, rheumatoid arthritis, pregnancy, and certain medications.

RLS/WED can have a significant impact on quality of life, and it is important to seek medical advice if symptoms are causing distress or disrupting daily activities. Treatment options include lifestyle changes, such as improving sleep hygiene and stopping substance use, as well as medication such as dopamine agonists and gabapentinoids.

Frequently asked questions